Chinese Academy of Medical Sciences: Colorectal Neoplasms trials

The registry lists 10 Colorectal Neoplasms studies with Chinese Academy of Medical Sciences as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 9No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced StageStatus unknownNCT05279677Phase 2
• Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal CancerStatus unknownNCT05016869Phase 1/2
• Regorafenib Treatment Patterns and Survival Outcomes in Advanced Colorectal Cancer: A Real-world StudyStatus unknownNCT04835324
• A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal CancerStatus unknownNCT04380103Phase 1/2
• A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal CancerCompletedNCT04247984Phase 2
• Phase II Study of Toripalimab Plus Stereotactic Body Radiotherapy in Colorectal Cancer Patients With OligometastasisStatus unknownNCT03927898Phase 2
• Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal CancerStatus unknownNCT03545711Phase 1/2
• Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal CancerStatus unknownNCT02688023Phase 2
• Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal CancerStatus unknownNCT01679327Phase 2
• Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal CancerStatus unknownNCT01529164Phase 2